Phathom Pharmaceuticals, Inc.

Biotechnology • Healthcare • Florham Park, NJ, United States • PHAT (NMS)

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Raymond James initiates Phathom Pharmaceuticals stock with Strong Buy rating - Investing.com

Investing.com • Dec 11

Phathom Pharmaceuticals grants RSUs and options to CEO Steven Basta | PHAT SEC Filing - Form 4 - Stock Titan

Stock Titan • Jan 2

With 51% ownership of the shares, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) is heavily dominated by institutional owners - Yahoo Finance

Yahoo Finance • Oct 28

Simplify Asset Management Inc. Reduces Position in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat

MarketBeat • Dec 30

Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth (NASDAQ:PHAT) - Seeking Alpha

Seeking Alpha • Nov 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Phathom Pharmaceuticals, Inc. had layoffs?

No layoff events have been recorded for Phathom Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Phathom Pharmaceuticals, Inc. have?

Phathom Pharmaceuticals, Inc. has approximately 427 employees.

What industry is Phathom Pharmaceuticals, Inc. in?

Phathom Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Phathom Pharmaceuticals, Inc. a publicly traded company?

Yes, Phathom Pharmaceuticals, Inc. is publicly traded under the ticker symbol PHAT on the NMS. The company has a market capitalization of approximately $1.26 billion.

Where is Phathom Pharmaceuticals, Inc. headquartered?

Phathom Pharmaceuticals, Inc. is headquartered in Florham Park, NJ, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.